Wall Street Zen Downgrades Nutex Health (NASDAQ:NUTX) to Hold

Key Points

• Wall Street Zen downgraded Nutex Health to “Hold” from “Buy,” though the broader analyst consensus remains “Buy” with a $317.50 price target.
• Other analysts remain bullish: Lake Street Capital raised its target to $310, while B. Riley lifted its target to $325 and reiterated a “Buy” rating.
• Nutex Health reported quarterly EPS of $9.38, beating estimates of $4.95, while shares opened at $193.24, near their 52-week high of $204.00.

Nutex Health (NASDAQ:NUTX - Get Free Report) was downgraded by Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday, Wall Street Zen reports.

Several other brokerages have also issued reports on NUTX. Lake Street Capital restated a "buy" rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. B Riley reiterated a "buy" rating on shares of Nutex Health in a research report on Friday. B. Riley Financial lifted their price target on shares of Nutex Health from $290.00 to $325.00 and gave the stock a "buy" rating in a research note on Friday. Weiss Ratings raised shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, July 28th. Finally, Zacks Research raised shares of Nutex Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Nutex Health has an average rating of "Buy" and a consensus price target of $317.50.

Nutex Health Stock Performance

Shares of NASDAQ NUTX opened at $193.24 on Friday. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. Nutex Health has a 52-week low of $80.53 and a 52-week high of $204.00. The company has a market cap of $1.32 billion, a PE ratio of 7.59 and a beta of 0.28. The firm's 50-day moving average price is $175.59 and its 200-day moving average price is $136.75.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The business had revenue of $210.75 million for the quarter, compared to analysts' expectations of $215.03 million.

Institutional Investors Weigh In On Nutex Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. California State Teachers Retirement System raised its stake in Nutex Health by 25,615.8% during the 2nd quarter. California State Teachers Retirement System now owns 934,768 shares of the company's stock worth $159,743,000 after acquiring an additional 931,133 shares during the period. BlackRock Inc. bought a new position in shares of Nutex Health in the second quarter worth approximately $69,612,000. Pertento Partners LLP boosted its position in shares of Nutex Health by 20.0% in the fourth quarter. Pertento Partners LLP now owns 324,422 shares of the company's stock worth $53,406,000 after purchasing an additional 54,001 shares during the period. Topline Capital Management LLC increased its stake in shares of Nutex Health by 72.0% in the second quarter. Topline Capital Management LLC now owns 309,131 shares of the company's stock worth $38,484,000 after purchasing an additional 129,418 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Nutex Health by 12.7% in the third quarter. Vanguard Group Inc. now owns 214,954 shares of the company's stock worth $22,209,000 after purchasing an additional 24,275 shares in the last quarter. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source